



The landscape of rheumatic and musculoskeletal disease research continues to evolve at pace, driven by scientific innovation, interdisciplinary collaboration and an increasing appreciation of the heterogeneity and complexity of the conditions we treat. As we welcome readers to touchREVIEWS in RMD Volume 5, Issue 1, we are reminded that progress in our field depends not […]
We often focus on clinical excellence, but spend less time developing broader skills that could help us better lead with purpose and build more fulfilling, impactful careers.
In this episode, part of a mini-series in partnership with LEADderm, Dr Jennifer Soung and Denise Mann explore how clinicians can engage with the media to educate, empower and extend their impact beyond the clinic.
In this Q&A Future Leader Dr Elisa Pose explores what first drew her pursue a career in hepatology, the most rewarding moment in her journey so far, and the most exciting current innovations in chronic liver disease.
Interstitial lung disease (ILD) is recognized as one of the most frequent and potentially life-threatening pulmonary complications of systemic autoimmune rheumatic diseases (SARDs), a group of rare chronic inflammatory conditions characterized by autoimmune system dysregulation and chronic systemic inflammation. ILDs are a heterogeneous group of lung disorders that are underpinned by varying degrees of inflammation and […]
Your clinical career is shaped not only by what you know, but by who helps you navigate what comes next. Join us for the final episode in our mini-series exploring non-clinical skills that can help you thrive in your clinical career. Today we explore how to develop the right team around you to support your work, and what building that bench can mean for your career, and the life you build alongside it.
We often focus on clinical excellence, but spend less time developing broader skills that could help us better lead with purpose and build more fulfilling, impactful careers. In this episode, part of a mini-series in partnership with LEADderm, Dr Jennifer Soung and Denise Mann explore how clinicians can engage with the media to educate, empower and extend their impact beyond the clinic.
Dear readers, It is a great pleasure to take on the role of Editor-in-Chief of touchREVIEWS in RMD, and I am grateful for the opportunity to introduce myself and to share my vision for the journal. I am a Professor ...
The landscape of rheumatic and musculoskeletal disease research continues to evolve at pace, driven by scientific innovation, interdisciplinary collaboration and an increasing appreciation of the heterogeneity and complexity of the conditions we treat. As we welcome readers to touchREVIEWS in ...
Long-term dual IL-17A/F inhibition in PsA and axSpA.
Explore practical approaches to recognising and managing hereditary angioedema (HAE) to optimise treatment outcomes and improve quality of life for patients living with the disease.
Share your knowledge, influence clinical practices and enhance patient care in Immunology today!
Interstitial lung disease (ILD) is recognized as one of the most frequent and potentially life-threatening pulmonary complications of systemic autoimmune rheumatic diseases (SARDs), a group of rare chronic inflammatory conditions characterized by autoimmune system dysregulation and chronic systemic inflammation. ILDs ...
The importance of multi-disciplinary clinics for the assessment of patients with interstitial lung disease (ILD) is well established, and these are usually led by chest physicians.1Â The role of rheumatologists in such a setting has evolved more recently.2Â The main ...
Whether you’re working in an agency, in a clinical role, or in academia, many healthcare professionals wonder what lies behind the doors of the pharmaceutical industry. In this episode, Gina is joined by Sian Kneller, Director of Global Content Design at GSK and Founder of The Agency Advantage, to unpack exactly what it takes to make the leap. With over 20 years’ experience, from medical writer to leading global medical affairs strategy, Sian now helps others make a successful move into pharma. In this episode she shares what the transition really looks like, which transferable skills matter most, and how you can stand out in a competitive field.
Virtual reality (VR) is an emergent technology with the potential for genuine impact as a novel, immersive digital therapeutic in healthcare. Within rheumatological conditions, pervasive symptoms including chronic pain and kinesiophobia (fear of movement) are difficult to manage using conventional ...
S3E3_Could senolytics change the treatment landscape of age-related diseases? In this episode, Nicky speaks with Prof. Georgina Ellison-Hughes from King’s College London about the groundbreaking field of senolytics and their potential to advance the treatment of age-related ...
Why do we need to identify arthritis? In children, joint pain occurs frequently; it is usually associated with activities or accidental falls and is generally short-lived. A small proportion of children have more persistent joint pain, and in this group, ...
In this episode we explore the concept of syndemics, how biology, society and the environment interact to shape health outcomes. We are joined by Dr Elena Nikiphorou (King’s College London), who is pioneering the use of syndemic thinking in inflammatory arthritis, and Dr Lisa Hamzah (St George’s Hospital, London), whose experience in HIV research offers unique insight into how this approach can transform care. Together we discuss how applying this framework, first developed in HIV research, could improve care for people with rheumatic and musculoskeletal diseases (RMDs) and help advance global health equity.
In this episode of Visionary Voices, we welcome Associate Professor Grace Vincent from CQUniversity’s Appleton Institute. A leading expert on sleep and shift work, Grace explores how disrupted sleep affects physician health in both the short and long term, as well as its impact on safety and performance. We also discuss what this means for patient outcomes and share practical strategies to manage sleep loss.
In this episode, we speak with leading paediatric allergist Prof. Helen Brough to explore the key factors behind why some children develop allergies to foods such as peanuts, and what we can do to help prevent them. We also examine the latest developments in managing food allergies and the innovations on the horizon that could transform how we treat them.
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
Join leading experts in EoE as they explore evolving guidelines, the role of type 2 inflammation, and the importance of long-term monitoring.
Watch consultant immunologists Dr Dalm and Dr Chandra outline what APDS is, the common features of this disease and option for diagnosis, treatment and management.
This year, we are celebrating our inaugural touchIMMUNOLOGY Future Leaders to recognize the outstanding talent that has entered our field in recent years. These individuals are set to innovate and transform the field in the years to come.
Representing a diverse range of expertise from across the globe, these highly accomplished clinicians are among the brightest minds shaping the future of immunology. We had the pleasure of learning about their unique career journeys, motivations and the inspirations that have guided their paths. They also shared their perspectives on the most exciting developments in immunology today, along with their hopes for the future of the field.
Dr Tom Appleton is a future leader in the field of rheumatology, known for his dual expertise as a clinician and scientist. Based at St. Joseph’s Health Care London and Western University’s Schulich School of Medicine & Dentistry, his research focuses on the inflammatory mechanisms underlying osteoarthritis (OA), particularly the role of synovial macrophages.
“My advice to aspiring clinician-scientists is to embrace this dual role, maintaining clear boundaries and leveraging the strengths each domain brings to the other.”
Dr Sonali Bracken is a physician-scientist specializing in rheumatology and immunology at Duke University. Dr Bracken is currently a fourth-year research fellow in the Division of Rheumatology and Immunology at Duke University Medical Center, where she focuses on understanding how B cells contribute to autoimmune diseases. In recognition of her outstanding contributions to rheumatology, Dr Bracken received the 2024 Distinguished Fellow Award from the American College of Rheumatology.
“It truly takes a village to raise a physician-scientist, and I am very grateful for all the individuals who have helped me along my career path.”
Dr Bram Verstockt, MD, PhD, is a leading clinician-scientist at University Hospitals Leuven and KU Leuven, whose work is rapidly shaping the future of inflammatory bowel disease (IBD) care. Dr Verstockt’s research interests span noninvasive monitoring with intestinal ultrasound, fatigue, IBD disease heterogeneity, intestinal organoids and precision medicine in IBD.
“Precision medicine is a hope we all have, but I think what we all still struggle with is the translation from the wet lab to the clinic.”
Dr Sham is a Senior Consultant Rheumatologist at Kauvery Hospitals, Chennai, India. In 2009, he earned his MD in general medicine from Kasturba Medical College and went on to specialise in rheumatology at Madras Medical College, Chennai. Dr Sham has extensive experience in treating a wide range of rheumatic diseases, with his current research focusing on systemic lupus erythematosus (SLE), vasculitis and interstitial lung disease (ILD).
“My long-term ambition is to make the management of AIRDs more patient-centric. I would like to empower patients by making them more aware of the disease, the management and expected outcomes.”
Dr Brian Jaros is an Assistant Professor of Medicine in the Division of Rheumatology at Northwestern University, where he also serves as Associate Program Director of the Rheumatology Fellowship and Associate Director of the Vasculitis Center. His clinical and academic interests focus on vasculitis and medical education.
“With an enormous work-force shortage looming in rheumatology, a focus on mentorship and training is more important than ever.”
Introducing the Editorial Board of touchREVIEWS in Immunology, who support our mission to advance medical knowledge and practice by ensuring the integrity, relevance, and impact of the content we publish. Together, we strive to foster a vibrant academic community and contribute to the continuous improvement of healthcare worldwide.

Rheumatoid Arthritis

Head of Clinical Sciences, Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
Peter C Taylor holds the Norman Collison chair of musculoskeletal sciences at the University of Oxford and is a Fellow of St. Peter’s College. He is Head of Clinical Sciences at the Botnar Research Centre within the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences. He studied pre-clinical medical sciences at Gonville and Caius College at the University of Cambridge and his first degree was in Physiology. He subsequently studied clinical medicine at the University of Oxford and was awarded a PhD degree from the University of London for research on pathogenesis of arthritis. Professor Taylor has specialist clinical interests in inflammatory arthritis. He has over 25 years’ experience in clinical trial design in studies of biologic and small molecular therapies in rheumatoid arthritis and ankylosing spondylitis. In experimental medicine studies, Professor Taylor employs targeted therapies as probes of pathogenesis to investigate the in vivo biology of the target in the pathobiology of the disease phenotype under investigation.

Preventive cardiology in rheumatology

Amsterdam Rheumatology & Immunology Center, Amsterdam University Medical Center and Reade, Amsterdam, The Netherlands
Michael T. Nurmohamed, MD PhD, is Professor Emeritus of Rheumatology and a consultant rheumatologist affiliated with the Amsterdam Rheumatology & Immunology Center at Reade and Amsterdam UMC, The Netherlands. His academic career has focused on the interface between inflammatory rheumatic diseases and cardiovascular disease, with a particular emphasis on cardiovascular risk management and prevention in conditions such as rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis and gout. He has played a leading role in European and international guideline development, including as convenor and chair of multiple EULAR task forces and study groups addressing cardiovascular involvement in inflammatory arthritis. His work has contributed to improved understanding of inflammation-driven atherosclerosis and to the implementation of cardiovascular risk assessment strategies in rheumatology care. Professor Nurmohamed has authored and co-authored numerous peer-reviewed publications and remains actively involved in international collaborations, clinical trials and educational initiatives. Following his emeritaat in November 2025, he remains actively involved in research, epidemiology, mentoring and international advisory roles within the rheumatology community, with a strong commitment to advancing interdisciplinary education and collaboration.

Rheumatic Diseases

Dr Vinod Ravindran’s clinical career includes training and consultant roles at premier institutions, such as King’s College Hospital, London and St. George’s University Hospital, London, Ipswich and Maidstone, UK.  Currently, he serves as the Director of the Centre for Rheumatology in Calicut, Kerala, India, where he leads comprehensive rheumatology services with a strong focus on multidisciplinary care.
In addition to his clinical leadership, he is an Adjunct Professor of Medicine at the Kasturba Medical College, Manipal, Karnataka, where he teaches postgraduates and supervises PhD research. He is the president-elect of the Indian Rheumatology Association. He has a keen interest in reproductive rheumatology and is the co-convener of the APLAR SIG for Women’s Health in AIRDs and Convener of the Indian Rheumatology Association’s Reproductive Rheumatology SIG.

Rheumatoid Arthritis

Centre for Rheumatic Diseases, School of Immunology and Microbial Sciences, King’s College London, London, UK
Dr Elena Nikiphorou is a Consultant Rheumatologist at King’s College Hospital and a Reader in Rheumatology and Medical Education at King’s College London. A recipient of several awards, including the Richard Kovacs Prize (Royal Society of Medicine, 2014) and the Doris Hillier Award (British Medical Association, 2018), her research focuses on multimorbidity in rheumatoid arthritis and the development of personalised management algorithms. Her clinical and academic interests focus on inflammatory arthritis, in particular rheumatoid arthritis and spondyloarthritis, with her latest research exploring the role of social determinants of health  in disease outcomes.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
Keep track of your clinical interests and newsletter subscriptions.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Already registered? Login below.